Utilizing Local Anti-Cancer Treatment and Online Medical Service During the COVID-19 Pandemic

Qi Wang,Zhouqiao Wu,Jinyao Shi,Kan Xue,Ziyu Li,Jiafu Ji
DOI: https://doi.org/10.2478/fzm-2021-0016
2021-01-01
Frigid Zone Medicine
Abstract:Since the first outbreak of the coronavirus disease (COVID-19) in the winter of 2019, this pandemic has resulted in significant global social and economic disruption, as well as global public health and medical crises[1]. Climate, weather conditions, and even latitude have now been acknowledged to be directly associated with COVID-19 outbreaks[2-4]. It was reported that 60% of the confirmed cases of COVID-19 occurred in areas where the air temperature ranged from 5℃ to 15℃[4]. These earlier research results strongly implied that the COVID-19 pandemic might spread cyclically and outbreaks might recur in large cities in the mid-latitudes (for example, the northern part of China) in autumn 2020[4], which has now been confirmed by the third wave of the pandemic. With quarantines and other restrictive legislations and control measures being put in action to contain the spread of the disease[5], the pandemic has also manifested additional obstacles in the treatment of other diseases. For example, a median dose delay of 14 (6-20) days was found in patients who received one cycle of gastric chemotherapy in our department from the first outbreak till the spring festival of 2020 (n = 79).
What problem does this paper attempt to address?